1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Regenerative Aesthetics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Regenerative Aesthetics Market Revenue and Volume, by Product & Service
8.1.1. Biologics & Cell Products
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Biomaterials & Fillers
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Combination Products / Drug-Device Hybrids
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Devices & Equipment
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Consumables & Single-use Kits
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Services
8.1.6.1. Market Revenue and Volume Forecast
9.1. Regenerative Aesthetics Market Revenue and Volume, by Technology / Modality
9.1.1. Autologous Biologics (PRP, microfat, SVF)
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Allogeneic Cell-Based Products
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Exosomes & Extracellular Vesicles
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Biomaterials & tissue scaffolds (ECM, collagen, synthetic scaffolds)
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Combination Biologic-Device Platforms
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Gene-Modified / Gene-Therapy Related Regenerative Products (Emerging)
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Advanced Delivery Systems (Microneedles, Patches, Carriers)
9.1.7.1. Market Revenue and Volume Forecast
10.1. Regenerative Aesthetics Market Revenue and Volume, by Indication / Application
10.1.1. Facial Rejuvenation & Volume Restoration
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hair Restoration
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Scar Revision & Acne Scarring
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Wound Healing & Reconstructive Adjuncts
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Body Contouring & Soft-Tissue Defect Repair
10.1.5.1. Market Revenue and Volume Forecast
11.1. Regenerative Aesthetics Market Revenue and Volume, by Procedure Type
11.1.1. Injectables
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Surgical Grafting / Fat Grafting
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Device-Assisted Combination Procedures
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Topical/Patch/Implantable Biomaterial Applications
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Outpatient Office Procedures / Ambulatory Surgical Procedures
11.1.5.1. Market Revenue and Volume Forecast
12.1. Regenerative Aesthetics Market Revenue and Volume, by End-User / Buyer
12.1.1. Dermatology Clinics & Aesthetic Physicians
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Plastic Surgery Clinics & Ambulatory Surgical Centers
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Med-Spas And Cosmetic Chains
12.1.3.1. Market Revenue and Volume Forecast
12.1.4. Hospitals & Wound Care Centers
12.1.4.1. Market Revenue and Volume Forecast
12.1.5. Hair Restoration Specialty Clinics
12.1.5.1. Market Revenue and Volume Forecast
12.1.6. Academic & Research Institutions (For Clinical-Stage Products)
12.1.6.1. Market Revenue and Volume Forecast
13.1. Regenerative Aesthetics Market Revenue and Volume, by Distribution Channel
13.1.1. Direct Sales To Clinics/Hospitals (Field Teams, Direct Rep)
13.1.1.1. Market Revenue and Volume Forecast
13.1.2. Medical Distributors & Dealers
13.1.2.1. Market Revenue and Volume Forecast
13.1.3. Online professional channels / OEM E-Commerce
13.1.3.1. Market Revenue and Volume Forecast
13.1.3. Clinic Franchising & Network Procurement
13.1.3.1. Market Revenue and Volume Forecast
13.1.3. Group Purchasing Organizations (GPOs) / Institutional Procurement
13.1.3.1. Market Revenue and Volume Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Product & Service
14.1.2. Market Revenue and Volume Forecast, by Technology / Modality
14.1.3. Market Revenue and Volume Forecast, by Indication / Application
14.1.4. Market Revenue and Volume Forecast, by Procedure Type
14.1.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.1.6. Market Revenue and Volume Forecast, by Distribution Channel
14.1.7. U.S.
14.1.7.1. Market Revenue and Volume Forecast, by Product & Service
14.1.7.2. Market Revenue and Volume Forecast, by Technology / Modality
14.1.7.3. Market Revenue and Volume Forecast, by Indication / Application
14.1.7.4. Market Revenue and Volume Forecast, by Procedure Type
14.1.8. Market Revenue and Volume Forecast, by End-User / Buyer
14.1.8.1. Market Revenue and Volume Forecast, by Distribution Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Product & Service
14.1.9.2. Market Revenue and Volume Forecast, by Technology / Modality
14.1.9.3. Market Revenue and Volume Forecast, by Indication / Application
14.1.9.4. Market Revenue and Volume Forecast, by Procedure Type
14.1.10. Market Revenue and Volume Forecast, by End-User / Buyer
14.1.11. Market Revenue and Volume Forecast, by Distribution Channel
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Product & Service
14.2.2. Market Revenue and Volume Forecast, by Technology / Modality
14.2.3. Market Revenue and Volume Forecast, by Indication / Application
14.2.4. Market Revenue and Volume Forecast, by Procedure Type
14.2.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.2.6. Market Revenue and Volume Forecast, by Distribution Channel
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Product & Service
14.2.8.2. Market Revenue and Volume Forecast, by Technology / Modality
14.2.8.3. Market Revenue and Volume Forecast, by Indication / Application
14.2.9. Market Revenue and Volume Forecast, by Procedure Type
14.2.10. Market Revenue and Volume Forecast, by End-User / Buyer
14.2.10.1. Market Revenue and Volume Forecast, by Distribution Channel
14.2.11. Germany
14.2.11.1. Market Revenue and Volume Forecast, by Product & Service
14.2.11.2. Market Revenue and Volume Forecast, by Technology / Modality
14.2.11.3. Market Revenue and Volume Forecast, by Indication / Application
14.2.12. Market Revenue and Volume Forecast, by Procedure Type
14.2.13. Market Revenue and Volume Forecast, by End-User / Buyer
14.2.14. Market Revenue and Volume Forecast, by Distribution Channel
14.2.15. France
14.2.15.1. Market Revenue and Volume Forecast, by Product & Service
14.2.15.2. Market Revenue and Volume Forecast, by Technology / Modality
14.2.15.3. Market Revenue and Volume Forecast, by Indication / Application
14.2.15.4. Market Revenue and Volume Forecast, by Procedure Type
14.2.16. Market Revenue and Volume Forecast, by End-User / Buyer
14.2.16.1. Market Revenue and Volume Forecast, by Distribution Channel
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Volume Forecast, by Product & Service
14.2.17.2. Market Revenue and Volume Forecast, by Technology / Modality
14.2.17.3. Market Revenue and Volume Forecast, by Indication / Application
14.2.17.4. Market Revenue and Volume Forecast, by Procedure Type
14.2.18. Market Revenue and Volume Forecast, by End-User / Buyer
14.2.18.1. Market Revenue and Volume Forecast, by Distribution Channel
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Product & Service
14.3.2. Market Revenue and Volume Forecast, by Technology / Modality
14.3.3. Market Revenue and Volume Forecast, by Indication / Application
14.3.4. Market Revenue and Volume Forecast, by Procedure Type
14.3.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.3.6. Market Revenue and Volume Forecast, by Distribution Channel
14.3.7. India
14.3.7.1. Market Revenue and Volume Forecast, by Product & Service
14.3.7.2. Market Revenue and Volume Forecast, by Technology / Modality
14.3.7.3. Market Revenue and Volume Forecast, by Indication / Application
14.3.7.4. Market Revenue and Volume Forecast, by Procedure Type
14.3.8. Market Revenue and Volume Forecast, by End-User / Buyer
14.3.9. Market Revenue and Volume Forecast, by Distribution Channel
14.3.10. China
14.3.10.1. Market Revenue and Volume Forecast, by Product & Service
14.3.10.2. Market Revenue and Volume Forecast, by Technology / Modality
14.3.10.3. Market Revenue and Volume Forecast, by Indication / Application
14.3.10.4. Market Revenue and Volume Forecast, by Procedure Type
14.3.11. Market Revenue and Volume Forecast, by End-User / Buyer
14.3.11.1. Market Revenue and Volume Forecast, by Distribution Channel
14.3.12. Japan
14.3.12.1. Market Revenue and Volume Forecast, by Product & Service
14.3.12.2. Market Revenue and Volume Forecast, by Technology / Modality
14.3.12.3. Market Revenue and Volume Forecast, by Indication / Application
14.3.12.4. Market Revenue and Volume Forecast, by Procedure Type
14.3.12.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.3.12.6. Market Revenue and Volume Forecast, by Distribution Channel
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Volume Forecast, by Product & Service
14.3.13.2. Market Revenue and Volume Forecast, by Technology / Modality
14.3.13.3. Market Revenue and Volume Forecast, by Indication / Application
14.3.13.4. Market Revenue and Volume Forecast, by Procedure Type
14.3.13.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.3.13.6. Market Revenue and Volume Forecast, by Distribution Channel
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Product & Service
14.4.2. Market Revenue and Volume Forecast, by Technology / Modality
14.4.3. Market Revenue and Volume Forecast, by Indication / Application
14.4.4. Market Revenue and Volume Forecast, by Procedure Type
14.4.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.4.6. Market Revenue and Volume Forecast, by Distribution Channel
14.4.7. GCC
14.4.7.1. Market Revenue and Volume Forecast, by Product & Service
14.4.7.2. Market Revenue and Volume Forecast, by Technology / Modality
14.4.7.3. Market Revenue and Volume Forecast, by Indication / Application
14.4.7.4. Market Revenue and Volume Forecast, by Procedure Type
14.4.8. Market Revenue and Volume Forecast, by End-User / Buyer
14.4.9. Market Revenue and Volume Forecast, by Distribution Channel
14.4.10. North Africa
14.4.10.1. Market Revenue and Volume Forecast, by Product & Service
14.4.10.2. Market Revenue and Volume Forecast, by Technology / Modality
14.4.10.3. Market Revenue and Volume Forecast, by Indication / Application
14.4.10.4. Market Revenue and Volume Forecast, by Procedure Type
14.4.11. Market Revenue and Volume Forecast, by End-User / Buyer
14.4.12. Market Revenue and Volume Forecast, by Distribution Channel
14.4.13. South Africa
14.4.13.1. Market Revenue and Volume Forecast, by Product & Service
14.4.13.2. Market Revenue and Volume Forecast, by Technology / Modality
14.4.13.3. Market Revenue and Volume Forecast, by Indication / Application
14.4.13.4. Market Revenue and Volume Forecast, by Procedure Type
14.4.13.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.4.13.6. Market Revenue and Volume Forecast, by Distribution Channel
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Volume Forecast, by Product & Service
14.4.14.2. Market Revenue and Volume Forecast, by Technology / Modality
14.4.14.3. Market Revenue and Volume Forecast, by Indication / Application
14.4.14.4. Market Revenue and Volume Forecast, by Procedure Type
14.4.14.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.4.14.6. Market Revenue and Volume Forecast, by Distribution Channel
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Product & Service
14.5.2. Market Revenue and Volume Forecast, by Technology / Modality
14.5.3. Market Revenue and Volume Forecast, by Indication / Application
14.5.4. Market Revenue and Volume Forecast, by Procedure Type
14.5.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.5.6. Market Revenue and Volume Forecast, by Distribution Channel
14.5.7. Brazil
14.5.7.1. Market Revenue and Volume Forecast, by Product & Service
14.5.7.2. Market Revenue and Volume Forecast, by Technology / Modality
14.5.7.3. Market Revenue and Volume Forecast, by Indication / Application
14.5.7.4. Market Revenue and Volume Forecast, by Procedure Type
14.5.8. Market Revenue and Volume Forecast, by End-User / Buyer
14.5.8.1. Market Revenue and Volume Forecast, by Distribution Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Product & Service
14.5.9.2. Market Revenue and Volume Forecast, by Technology / Modality
14.5.9.3. Market Revenue and Volume Forecast, by Indication / Application
14.5.9.4. Market Revenue and Volume Forecast, by Procedure Type
14.5.9.5. Market Revenue and Volume Forecast, by End-User / Buyer
14.5.9.6. Market Revenue and Volume Forecast, by Distribution Channel
15.1. Cutera
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Venus Concept
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Anika Therapeutics
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. CollPlant
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. RegenLab
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. EmCyte
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Lipogems
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Suneva Medical
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Integra LifeSciences
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Arthrex
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client